Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
DexCom Analyst Ratings and Price Targets | NASDAQ:DXCM | Benzinga
DexCom Inc has a consensus price target of $121.6 based on the ratings of 25 analysts. The high is $500 issued by SVB Leerink on April 29, 2022. The low is $82 issued by Morgan Stanley on February 14, 2025. The 3 most-recent analyst ratings were released by Citigroup, Canaccord Genuity, and Morgan Stanley on March 4, 2025, February 14, 2025, and February 14, 2025, respectively. With an average price target of $96.33 between Citigroup, Canaccord Genuity, and Morgan Stanley, there's an implied 32.21% upside for DexCom Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Canaccord Genuity
Morgan Stanley
Redburn Atlantic
Baird
1calculated from analyst ratings
Analyst Ratings for DexCom
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/04/2025 | Buy Now | 42.73% | Citigroup | Joanne Wuensch75% | $101 → $104 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 41.36% | Canaccord Genuity | William Plovanic58% | $99 → $103 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 12.54% | Morgan Stanley | Patrick Wood52% | $75 → $82 | Maintains | Equal-Weight | Get Alert |
| 02/03/2025 | Buy Now | 57.83% | Redburn Atlantic | Issie Kirby25% | $85 → $115 | Upgrade | Neutral → Buy | Get Alert |
| 01/16/2025 | Buy Now | 42.73% | Baird | Jeff Johnson77% | $86 → $104 | Upgrade | Neutral → Outperform | Get Alert |
| 12/11/2024 | Buy Now | 24.89% | Citigroup | Joanne Wuensch75% | $85 → $91 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 29.01% | Wells Fargo | Larry Biegelsen69% | $90 → $94 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | 35.87% | Canaccord Genuity | William Plovanic58% | $89 → $99 | Maintains | Buy | Get Alert |
| 10/25/2024 | Buy Now | 18.03% | Bernstein | Lee Hambright68% | $82 → $86 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 35.87% | Raymond James | Jayson Bedford69% | $115 → $99 | Maintains | Strong Buy | Get Alert |
| 10/25/2024 | Buy Now | 57.83% | RBC Capital | Shagun Singh58% | $120 → $115 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 44.1% | Oppenheimer | Steven Lichtman66% | $115 → $105 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 16.65% | JP Morgan | Robbie Marcus67% | $75 → $85 | Maintains | Neutral | Get Alert |
| 10/25/2024 | Buy Now | 19.4% | Leerink Partners | Mike Kratky66% | $90 → $87 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 23.52% | Wells Fargo | Larry Biegelsen69% | $80 → $90 | Maintains | Overweight | Get Alert |
| 10/08/2024 | Buy Now | 64.69% | RBC Capital | Shagun Singh58% | $130 → $120 | Maintains | Outperform | Get Alert |
| 08/26/2024 | Buy Now | 23.52% | Piper Sandler | Matt O'Brien51% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 08/23/2024 | Buy Now | 37.24% | Stifel | Mathew Blackman62% | $90 → $100 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | 12.54% | Baird | Jeff Johnson77% | $80 → $82 | Maintains | Neutral | Get Alert |
| 07/29/2024 | Buy Now | 55.08% | Barclays | Matt Miksic67% | $138 → $113 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | 9.79% | Baird | Jeff Johnson77% | $161 → $80 | Downgrade | Outperform → Neutral | Get Alert |
| 07/26/2024 | Buy Now | 64.69% | BTIG | Marie Thibault64% | $156 → $120 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 2.93% | Morgan Stanley | Patrick Wood52% | $120 → $75 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | 57.83% | Oppenheimer | Steven Lichtman66% | $150 → $115 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 30.38% | UBS | Danielle Antalffy58% | $163 → $95 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 23.52% | Stifel | Mathew Blackman62% | $132 → $90 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 23.52% | Piper Sandler | Matt O'Brien51% | $150 → $90 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 99% | RBC Capital | Shagun Singh58% | $165 → $145 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 9.79% | Wells Fargo | Larry Biegelsen69% | $145 → $80 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 22.14% | Canaccord Genuity | William Plovanic58% | $145 → $89 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 2.93% | JP Morgan | Robbie Marcus67% | $145 → $75 | Downgrade | Overweight → Neutral | Get Alert |
| 07/23/2024 | Buy Now | 99% | Canaccord Genuity | William Plovanic58% | $145 → $145 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 64.69% | Morgan Stanley | Patrick Wood52% | $132 → $120 | Maintains | Equal-Weight | Get Alert |
| 07/12/2024 | Buy Now | 81.16% | Stifel | Mathew Blackman62% | $145 → $132 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 78.41% | Redburn Atlantic | Issie Kirby25% | → $130 | Initiates | → Neutral | Get Alert |
| 04/26/2024 | Buy Now | 119.58% | Raymond James | Jayson Bedford69% | $151 → $160 | Maintains | Strong Buy | Get Alert |
| 04/26/2024 | Buy Now | 99% | Canaccord Genuity | William Plovanic58% | $144 → $145 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 123.7% | UBS | Danielle Antalffy58% | $153 → $163 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 120.96% | Citigroup | Joanne Wuensch75% | $148 → $161 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 126.45% | RBC Capital | Shagun Singh58% | → $165 | Initiates | → Outperform | Get Alert |
| 01/23/2024 | Buy Now | 107.23% | Raymond James | Jayson Bedford69% | $147 → $151 | Maintains | Strong Buy | Get Alert |
| 01/03/2024 | Buy Now | 101.74% | Raymond James | Jayson Bedford69% | $131 → $147 | Maintains | Strong Buy | Get Alert |
| 12/19/2023 | Buy Now | 105.86% | Piper Sandler | Matt O'Brien51% | $135 → $150 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | 86.65% | Wells Fargo | Larry Biegelsen69% | $110 → $136 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | 67.43% | Morgan Stanley | Patrick Wood52% | $101 → $122 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | Buy Now | 38.61% | Morgan Stanley | Patrick Wood52% | $98 → $101 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | 37.24% | JP Morgan | Michael Weinstein74% | $160 → $100 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | 50.96% | Leerink Partners | Mike Kratky66% | → $110 | Initiates | → Outperform | Get Alert |
| 10/10/2023 | Buy Now | 99% | Stifel | Mathew Blackman62% | $155 → $145 | Maintains | Buy | Get Alert |
| 09/29/2023 | Buy Now | 34.5% | Morgan Stanley | Patrick Wood52% | $131 → $98 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | Buy Now | 79.78% | Raymond James | Jayson Bedford69% | $154 → $131 | Maintains | Strong Buy | Get Alert |
| 09/06/2023 | Buy Now | 89.39% | UBS | Danielle Antalffy58% | $175 → $138 | Maintains | Buy | Get Alert |
| 08/21/2023 | Buy Now | 78.41% | Baird | Jeff Johnson77% | $153 → $130 | Maintains | Outperform | Get Alert |
| 07/31/2023 | Buy Now | 89.39% | Barclays | Matt Miksic67% | $115 → $138 | Maintains | Equal-Weight | Get Alert |
| 07/28/2023 | Buy Now | 119.58% | Piper Sandler | Matt O'Brien51% | $150 → $160 | Maintains | Overweight | Get Alert |
| 07/28/2023 | Buy Now | 105.86% | Canaccord Genuity | Kyle Rose66% | $135 → $150 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 111.35% | Raymond James | Jayson Bedford69% | $140 → $154 | Maintains | Strong Buy | Get Alert |
| 07/28/2023 | Buy Now | 109.98% | Baird | Jeff Johnson77% | $145 → $153 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | 105.86% | Citigroup | Joanne Wuensch75% | $146 → $150 | Maintains | Buy | Get Alert |
| 06/26/2023 | Buy Now | 105.86% | BTIG | Marie Thibault64% | $134 → $150 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | 79.78% | Morgan Stanley | Patrick Wood52% | → $131 | Assumes | → Equal-Weight | Get Alert |
| 05/01/2023 | Buy Now | 57.83% | Barclays | Matt Miksic67% | $110 → $115 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 92.14% | Stifel | Mathew Blackman62% | $130 → $140 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 83.9% | BTIG | Marie Thibault64% | $132 → $134 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 85.27% | Canaccord Genuity | Kyle Rose66% | $125 → $135 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 92.14% | Raymond James | Jayson Bedford69% | $138 → $140 | Maintains | Strong Buy | Get Alert |
| 04/17/2023 | Buy Now | 81.16% | BTIG | Marie Thibault64% | $126 → $132 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 89.39% | Raymond James | Jayson Bedford69% | $127 → $138 | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/29/2023 | Buy Now | 94.88% | UBS | Danielle Antalffy58% | → $142 | Initiates | → Buy | Get Alert |
| 02/13/2023 | Buy Now | 50.96% | Barclays | Matt Miksic67% | $103 → $110 | Maintains | Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | 71.55% | Cowen & Co. | Joshua Jennings55% | $114 → $125 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | 66.06% | Wolfe Research | Mike Polark55% | → $121 | Initiates | → Outperform | Get Alert |
| 01/06/2023 | Buy Now | 79.78% | Morgan Stanley | Cecilia Furlong49% | $117 → $131 | Maintains | Equal-Weight | Get Alert |
| 12/12/2022 | Buy Now | 100.37% | Citigroup | Joanne Wuensch75% | $117 → $146 | Maintains | Buy | Get Alert |
| 10/28/2022 | Buy Now | 60.57% | Morgan Stanley | Cecilia Furlong49% | $107 → $117 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | 75.67% | Wells Fargo | Larry Biegelsen69% | $102 → $128 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 71.55% | Raymond James | Jayson Bedford69% | $101 → $125 | Maintains | Outperform | Get Alert |
| 10/18/2022 | Buy Now | 41.36% | Barclays | Matt Miksic67% | → $103 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | 71.55% | Jefferies | Matthew Taylor67% | → $125 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 46.85% | Morgan Stanley | Cecilia Furlong49% | $83 → $107 | Maintains | Equal-Weight | Get Alert |
| 10/10/2022 | Buy Now | 50.96% | BTIG | Marie Thibault64% | $92 → $110 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 64.69% | Stifel | Mathew Blackman62% | $112 → $120 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 64.69% | Piper Sandler | Matt O'Brien51% | $110 → $120 | Maintains | Overweight | Get Alert |
| 08/01/2022 | Buy Now | 38.61% | Raymond James | Jayson Bedford69% | $122 → $101 | Maintains | Outperform | Get Alert |
| 07/29/2022 | Buy Now | 13.91% | Morgan Stanley | Cecilia Furlong49% | $91 → $83 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | Buy Now | 50.96% | Piper Sandler | Matt O'Brien51% | $120 → $110 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | 44.1% | Bernstein | Lee Hambright68% | → $105 | Initiates | → Outperform | Get Alert |
| 06/24/2022 | Buy Now | 44.1% | BTIG | Marie Thibault64% | $135 → $105 | Maintains | Buy | Get Alert |
| 06/15/2022 | Buy Now | 24.89% | Morgan Stanley | David Lewis70% | $90.75 → $91 | Maintains | Equal-Weight | Get Alert |
| 06/13/2022 | Buy Now | 24.55% | Morgan Stanley | David Lewis70% | $363 → $90.75 | Maintains | Equal-Weight | Get Alert |
| 06/07/2022 | Buy Now | 398.18% | Morgan Stanley | David Lewis70% | $123 → $90.75 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | Buy Now | 620.51% | Citigroup | Joanne Wuensch75% | $157.5 → $131.25 | Maintains | Buy | Get Alert |
| 04/29/2022 | Buy Now | 566.99% | Raymond James | Jayson Bedford69% | $134.5 → $121.5 | Maintains | Outperform | Get Alert |
| 04/29/2022 | Buy Now | 575.22% | Morgan Stanley | David Lewis70% | $128.5 → $123 | Maintains | Equal-Weight | Get Alert |
| 04/29/2022 | Buy Now | 558.75% | Piper Sandler | Matt O'Brien51% | $181.25 → $120 | Maintains | Overweight | Get Alert |
| 04/29/2022 | Buy Now | 586.2% | SVB Leerink | Danielle Antalffy58% | $141.25 → $125 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for DexCom (DXCM) stock?
The latest price target for DexCom (NASDAQ:DXCM) was reported by Citigroup on March 4, 2025. The analyst firm set a price target for $104.00 expecting DXCM to rise to within 12 months (a possible 42.73% upside). 39 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DexCom (DXCM)?
The latest analyst rating for DexCom (NASDAQ:DXCM) was provided by Citigroup, and DexCom maintained their buy rating.
When was the last upgrade for DexCom (DXCM)?
The last upgrade for DexCom Inc happened on February 3, 2025 when Redburn Atlantic raised their price target to $115. Redburn Atlantic previously had a neutral for DexCom Inc.
When was the last downgrade for DexCom (DXCM)?
The last downgrade for DexCom Inc happened on July 26, 2024 when Baird changed their price target from $161 to $80 for DexCom Inc.
When is the next analyst rating going to be posted or updated for DexCom (DXCM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DexCom, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DexCom was filed on March 4, 2025 so you should expect the next rating to be made available sometime around March 4, 2026.
Is the Analyst Rating DexCom (DXCM) correct?
While ratings are subjective and will change, the latest DexCom (DXCM) rating was a maintained with a price target of $101.00 to $104.00. The current price DexCom (DXCM) is trading at is $72.86, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.